Publications by authors named "Joby Jose"

Claim this Profile
G
Growth dynamics of Indian infants using latent trajectory models in pooled survey datasets.
Aswathi Saji, Jeswin Baby, Prem Antony, Srishti Sinha, Sulagna Bandyopadhyay, Joby K Jose

Front Public Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A charge reversal approach for the sensitive quantification of dicarboxylic acids using Liquid chromatography-tandem mass spectrometry.
Joby Jose, Alfred N Fonteh

J Chromatogr A· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress-strength reliability estimation involving paired observation with ties using bivariate exponentiated half-logistic model.
Thomas Xavier, Joby K Jose

J Appl Stat· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists.
Gill Holdsworth, Kevin Greenslade, Joby Jose, Zofia Stencel, Hishani Kirby

Bone· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural characterization of a novel derivative of myricetin from Mimosa pudica as an anti-proliferative agent for the treatment of cancer.
Joby Jose, A T Dhanya, Karickal R Haridas, T M Sumesh Kumar, Sony Jayaraman

Biomed Pharmacother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.
John-Paul Silva, Olivia Vetterlein, Joby Jose, Shirley Peters, Hishani Kirby

J Biol Chem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of olokizumab, an anti-IL-6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study.
Kosmas Kretsos, Georg Golor, Astrid Jullion, Matthew Hickling, Suzanne McCabe, Joby Jose

Clin Pharmacol Drug Dev· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis